A population-based five-year follow-up study of cervical human papillomavirus infection

被引:69
作者
Elfgren, K
Kalantari, M
Moberger, B
Hagmar, B
Dillner, J
机构
[1] Huddinge Univ Hosp, Dept Obstet & Gynecol, S-14186 Huddinge, Sweden
[2] Huddinge Univ Hosp, Dept Clin Virol, S-14186 Huddinge, Sweden
[3] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden
[4] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-10401 Stockholm, Sweden
[5] Rikshosp, Dept Pathol, Oslo, Norway
[6] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
关键词
clearance; human papillomavirus screening; persistence; polymerase chain reaction; sexual history;
D O I
10.1067/mob.2000.106749
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The purpose of this study was to determine the long-term tendency for cervical human papillomavirus infections to persist in the general population. STUDY DESIGN: From 500 women who participated in a 1991 population-based survey, 90 healthy women with normal results of cytologic examination (women with human papillomavirus deoxyribonucleic acid detected and age-matched control women without human papillomavirus deoxyribonucleic acid detected) were interviewed and examined 5 years later colposcopically, cytologically, and with human papillomavirus serologic testing and human papillomavirus deoxyribonucleic acid testing by polymerase chain reaction with 2 different consensus primer pairs (MY09 and MY11 and GP5(+) and GP6(+)), type-specific polymerase chain reaction, and deoxyribonucleic acid sequencing. RESULTS: The 5-year human papillomavirus clearance rate was 92%. Only human papillomavirus type 16 infections persisted. Colposcopic impression of grade 2 cervical intraepithelial neoplasia was associated with persistent human papillomavirus 16 infection (P<.03). Human papillomavirus detection was associated with sexual history. Human papillomavirus type was the only determinant of human papillomavirus persistence. CONCLUSION: The high clearance rates in a population-based setting with a 5-year follow-up period imply that inclusion of human papillomavirus deoxyribonucleic acid testing in population-based cervical screening programs should target persistent infection.
引用
收藏
页码:561 / 567
页数:7
相关论文
共 28 条
[11]   ASSOCIATION OF SERUM IMMUNOGLOBULIN-G ANTIBODIES AGAINST HUMAN PAPILLOMAVIRUS TYPE-16 CAPSIDS WITH ANAL EPIDERMOID CARCINOMA [J].
HEINO, P ;
EKLUND, C ;
FREDERIKSSONSHANAZARIAN, V ;
GOLDMAN, S ;
SCHILLER, JT ;
DILLNER, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (06) :437-440
[12]   PERSISTENCE OF TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS INFECTION AMONG CYTOLOGICALLY NORMAL WOMEN [J].
HILDESHEIM, A ;
SCHIFFMAN, MH ;
GRAVITT, PE ;
GLASS, AG ;
GREER, CE ;
ZHANG, T ;
SCOTT, DR ;
RUSH, BB ;
LAWLER, P ;
SHERMAN, ME ;
KURMAN, RJ ;
MANES, MM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :235-240
[13]   TRANSIENCE OF CERVICAL HPV INFECTION IN SEXUALLY ACTIVE, YOUNG-WOMEN WITH NORMAL CERVICOVAGINAL CYTOLOGY [J].
HINCHLIFFE, SA ;
VANVELZEN, D ;
KORPORAAL, H ;
KOK, PL ;
BOON, ME .
BRITISH JOURNAL OF CANCER, 1995, 72 (04) :943-945
[14]   PERSISTENT GENITAL HUMAN PAPILLOMAVIRUS INFECTION AS A RISK FACTOR FOR PERSISTENT CERVICAL DYSPLASIA [J].
HO, GYF ;
BURK, RD ;
KLEIN, S ;
KADISH, AS ;
CHANG, CJ ;
PALAN, P ;
BASU, J ;
TACHEZY, R ;
LEWIS, R ;
ROMNEY, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18) :1365-1371
[15]   Natural history of cervicovaginal papillomavirus infection in young women [J].
Ho, GYF ;
Bierman, R ;
Beardsley, L ;
Chang, CJ ;
Burk, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :423-428
[16]  
Hopman E H, 1998, Obstet Gynecol Surv, V53, P97, DOI 10.1097/00006254-199802000-00021
[17]  
HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
[18]   LIFETIME NUMBER OF PARTNERS AS THE ONLY INDEPENDENT RISK FACTOR FOR HUMAN PAPILLOMAVIRUS INFECTION - A POPULATION-BASED STUDY [J].
KARLSSON, R ;
JONSSON, M ;
EDLUND, K ;
EVANDER, M ;
GUSTAVSSON, A ;
BODEN, E ;
RYLANDER, E ;
WADELL, G .
SEXUALLY TRANSMITTED DISEASES, 1995, 22 (02) :119-127
[19]   A COHORT STUDY OF THE RISK OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE-2 OR GRADE-3 IN RELATION TO PAPILLOMAVIRUS INFECTION [J].
KOUTSKY, LA ;
HOLMES, KK ;
CRITCHLOW, CW ;
STEVENS, CE ;
PAAVONEN, J ;
BECKMANN, AM ;
DEROUEN, TA ;
GALLOWAY, DA ;
VERNON, D ;
KIVIAT, NB .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18) :1272-1278
[20]  
MANOS MM, 1989, CANCER CEL, V7, P209